RVG29-modified MicroRNA-loaded Nanoparticles Improve Ischemic Brain Injury by Nasal Delivery

Overview

Journal Drug Deliv

Specialty Pharmacology

Date 2020 May 14

PMID 32400219

Citations 28

Authors

Rubin Hao

Bixi Sun

Lihua Yang

Chun Ma

Shuling Li

Affiliations

Soon will be listed here.

Abstract

Effective nose-to-brain delivery needs to be developed to treat neurodegenerative diseases. Regulating miR-124 can effectively improve the symptoms of ischemic brain injury and provide a certain protective effect from brain damage after cerebral ischemia. We used rat models of middle cerebral artery occlusion (t-MCAO) with ischemic brain injury, and we delivered RVG29-NPs-miR124 intranasally to treat neurological damage after cerebral ischemia. Rhoa and neurological scores in rats treated by intranasal administration of RVG29-PEG-PLGA/miRNA-124 were significantly lower than those in PEG-PLGA/miRNA-124 nasal administration and RVG29-PLGA/miRNA-124 nasal administration group treated rats. These results indicate that the nose-to-brain delivery of PLGA/miRNA-124 conjugated with PEG and RVG29 alleviated the symptoms of cerebral ischemia-reperfusion injury. Thus, nasal delivery of RVG29-PEG-PLGA/miRNA-124 could be a new method for treating neurodegenerative diseases.

Citing Articles

Biomimetic astrocyte cell membrane-fused nanovesicles for protecting neurovascular units in hypoxic ischemic encephalopathy.

Liu Z, Xia Q, Wang C, Xu J, Tian K, Wang Z J Nanobiotechnology. 2024; 22(1):766.

PMID: 39695691 PMC: 11656965. DOI: 10.1186/s12951-024-03053-8.

The role of nanomaterials in revolutionizing ischemic stroke treatment: Current trends and future prospects.

Wang Y, Che H, Qu L, Lu X, Dong M, Sun B iScience. 2024; 27(12):111373.

PMID: 39669428 PMC: 11634991. DOI: 10.1016/j.isci.2024.111373.

Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals.

Akpinar Adscheid S, Tureli A, Gunday-Tureli N, Schneider M Beilstein J Nanotechnol. 2024; 15:1400-1414.

PMID: 39559726 PMC: 11572074. DOI: 10.3762/bjnano.15.113.

The application of nanoparticles in delivering small RNAs for cancer therapy.

Zhou T, Qiu J, Han X, Zhang X, Wang P, Xie S Discov Oncol. 2024; 15(1):500.

PMID: 39331172 PMC: 11436575. DOI: 10.1007/s12672-024-01341-1.

Apelin-13-Loaded Macrophage Membrane-Encapsulated Nanoparticles for Targeted Ischemic Stroke Therapy via Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis.

Ma C, Ma Y, Han B, Duan W, Meng S, Bai M Int J Nanomedicine. 2024; 19:9175-9193.

PMID: 39263632 PMC: 11389709. DOI: 10.2147/IJN.S475915.

References

Yu J, Chung K, Deo M, Thompson R, Turner D . MicroRNA miR-124 regulates neurite outgrowth during neuronal differentiation. Exp Cell Res. 2008; 314(14):2618-33. PMC: 2702206. DOI: 10.1016/j.yexcr.2008.06.002. View

Walchli T, Pernet V, Weinmann O, Shiu J, Guzik-Kornacka A, Decrey G . Nogo-A is a negative regulator of CNS angiogenesis. Proc Natl Acad Sci U S A. 2013; 110(21):E1943-52. PMC: 3666688. DOI: 10.1073/pnas.1216203110. View

Chen W, Zhan C, Gu B, Meng Q, Wang H, Lu W . Targeted brain delivery of itraconazole via RVG29 anchored nanoparticles. J Drug Target. 2010; 19(3):228-34. DOI: 10.3109/1061186X.2010.492523. View

Berger S, Fernandez-Lamo I, Schonig K, Moya S, Ehses J, Schieweck R . Forebrain-specific, conditional silencing of Staufen2 alters synaptic plasticity, learning, and memory in rats. Genome Biol. 2017; 18(1):222. PMC: 5693596. DOI: 10.1186/s13059-017-1350-8. View

Kamei N, Tanaka M, Choi H, Okada N, Ikeda T, Itokazu R . Effect of an Enhanced Nose-to-Brain Delivery of Insulin on Mild and Progressive Memory Loss in the Senescence-Accelerated Mouse. Mol Pharm. 2017; 14(3):916-927. DOI: 10.1021/acs.molpharmaceut.6b01134. View

Marangon D, Raffaele S, Fumagalli M, Lecca D . MicroRNAs change the games in central nervous system pharmacology. Biochem Pharmacol. 2019; 168:162-172. DOI: 10.1016/j.bcp.2019.06.019. View

Jiao S, Liu Y, Yao Y, Teng J . miR-124 promotes proliferation and neural differentiation of neural stem cells through targeting DACT1 and activating Wnt/β-catenin pathways. Mol Cell Biochem. 2018; 449(1-2):305-314. DOI: 10.1007/s11010-018-3367-z. View

Cook R, Householder K, Chung E, Prakapenka A, DiPerna D, Sirianni R . A critical evaluation of drug delivery from ligand modified nanoparticles: Confounding small molecule distribution and efficacy in the central nervous system. J Control Release. 2015; 220(Pt A):89-97. PMC: 4688251. DOI: 10.1016/j.jconrel.2015.10.013. View

Kim H, Choi H, Park J, Kim M, Lee H, Petersen R . Regulation of RhoA activity by the cellular prion protein. Cell Death Dis. 2017; 8(3):e2668. PMC: 5386549. DOI: 10.1038/cddis.2017.37. View

10.

Pardeshi C, Belgamwar V . Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting. Expert Opin Drug Deliv. 2013; 10(7):957-72. DOI: 10.1517/17425247.2013.790887. View

11.

Wang Z, Lu G, Sze J, Liu Y, Lin S, Yao H . Plasma miR-124 Is a Promising Candidate Biomarker for Human Intracerebral Hemorrhage Stroke. Mol Neurobiol. 2017; 55(7):5879-5888. PMC: 5994210. DOI: 10.1007/s12035-017-0808-8. View

12.

Gu X, Fu C, Lin L, Liu S, Su X, Li A . miR-124 and miR-9 mediated downregulation of HDAC5 promotes neurite development through activating MEF2C-GPM6A pathway. J Cell Physiol. 2017; 233(1):673-687. DOI: 10.1002/jcp.25927. View

13.

Sanna M, Quattrone A, Ghelardini C, Galeotti N . PKC-mediated HuD-GAP43 pathway activation in a mouse model of antiretroviral painful neuropathy. Pharmacol Res. 2014; 81:44-53. DOI: 10.1016/j.phrs.2014.02.004. View

14.

Wang J, Wang W, Zhai H . MicroRNA-124 Enhances Dopamine Receptor Expression and Neuronal Proliferation in Mouse Models of Parkinson's Disease via the Hedgehog Signaling Pathway by Targeting EDN2. Neuroimmunomodulation. 2019; 26(4):174-187. DOI: 10.1159/000501339. View

15.

Piwecka M, Glazar P, Hernandez-Miranda L, Memczak S, Wolf S, Rybak-Wolf A . Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function. Science. 2017; 357(6357). DOI: 10.1126/science.aam8526. View

16.

Gan L, Li Z, Lv Q, Huang W . Rabies virus glycoprotein (RVG29)-linked microRNA-124-loaded polymeric nanoparticles inhibit neuroinflammation in a Parkinson's disease model. Int J Pharm. 2019; 567:118449. DOI: 10.1016/j.ijpharm.2019.118449. View

17.

Adlakha Y, Saini N . Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128. Mol Cancer. 2014; 13:33. PMC: 3936914. DOI: 10.1186/1476-4598-13-33. View

18.

Muzzi L, Hassink G, Levers M, Jansman M, Frega M, Hofmeijer J . Mild stimulation improves neuronal survival in an in vitro model of the ischemic penumbra. J Neural Eng. 2019; 17(1):016001. DOI: 10.1088/1741-2552/ab51d4. View

19.

Yang Y, Ye Y, Kong C, Su X, Zhang X, Bai W . MiR-124 Enriched Exosomes Promoted the M2 Polarization of Microglia and Enhanced Hippocampus Neurogenesis After Traumatic Brain Injury by Inhibiting TLR4 Pathway. Neurochem Res. 2019; 44(4):811-828. DOI: 10.1007/s11064-018-02714-z. View

20.

Fonseca A, Ferro J . Cryptogenic stroke. Eur J Neurol. 2015; 22(4):618-23. DOI: 10.1111/ene.12673. View